System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Manish Modi, MD is an expert in Neurology at Post Graduate Institute of Medical Education and Research (India). As of October 2026, ScienceLeadR ranks Manish Modi in the top 1% of experts in India for Meningitis. Manish Modi has authored 303 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 677 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Manish Modi, MD Post Graduate Institute of Medical Education and Research India
677 ScienceLeadR Reputation 677

Unlock

Register Login
Network Map

Neurology

Subspecialties: Infectiology - Pharmacy - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Post Graduate Institute of Medical Education and Research

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 303

Citations

Citations: 3 399 1st author: 24 Last author: 43 Unique author: 0

Main journals

J Neurol Sci 22
Neurol India 22
Neurology 14
Ann Indian Acad Neurol 13
Endocrine Abstracts 7

Best Journals

Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Etiological Spectrum of Hyponatremia in Tuberculous Meningitis: Insights from Referral Institute in Northern India.
PMID 42902663 — mortality, serum, hyponatremia, polymerase chain reaction, tuberculosis, meningeal, brain, cranial nerves, meningitis, tuberculosis, prevalence, seizures, hydrocephalus		J Assoc Physicians India20260
Helicobacter pylori eradication therapy and clinical outcomes in Parkinson's disease: a double-blind randomized placebo-controlled trial.
PMID 42579018 — quality of life, helicobacter pylori, parkinson disease, helicobacter, signs and symptoms, neurosciences, therapeutics		Neurol Sci20260
Truenat MTB Plus Assay for Diagnosing Extrapulmonary Tuberculosis and Detecting Resistance to Rifampicin and Isoniazid.
PMID 42568745 — pharmaceutical preparations, tuberculosis, isoniazid, rifampin, tuberculosis, extrapulmonary		Indian J Microbiol20253
Detection of drug-resistant Extrapulmonary tuberculosis by Xpert® MTB/XDR assay - a comparison with phenotypic drug susceptibility testing and line probe assay.
PMID 42526642 — research design, pharmaceutical preparations, microbiology, tuberculosis, tuberculosis, extrapulmonary		Indian J Med Microbiol20260
hsa-miR-885-5p As Post Transcription Regulator of Matrix metalloproteinase 9 in Tuberculous Meningitis.
PMID 42500334 — matrix metalloproteinase 9, tuberculosis, meningeal, meningitis, matrix metalloproteinases, metalloproteases		Indian J Clin Biochem20241

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1
Phase 4 1

By status:

Active not recruiting 1
Completed 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858 — safety, muscles, pharmaceutical preparations, work, research, therapeutics, myasthenia gravis		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS